Promotion of Knee Cartilage Degradation by IκB Kinase ε in the Pathogenesis of Osteoarthritis in Human and Murine Models
Arthritis & Rheumatology · 2023
DOI: 10.1002/art.42421 ↗Kurz gefasst
Fachartikel in der Zeitschrift Arthritis & Rheumatology, 2023. Verfasst von Taisuke Uchida und 10 weiteren Autor:innen. Beteiligte Einrichtung: Kyushu University, Fukuoka, Japan. Hauptthemen laut MEDLINE: Osteoarthritis, Cartilage, Articular. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 46 Literaturangaben. Gefördert von: Japan Agency for Medical Research and Development, Japan Society for the Promotion of Science.
Abstract (Originalsprache)
Objective
NF‐κB signaling is an important modulator in osteoarthritis (OA), and IκB kinase ε (IKKε) regulates the NF‐κB pathway. This study was undertaken to identify the functional involvement of IKKε in the pathogenesis of OA and the effectiveness of IKKε inhibition as a modulatory treatment.
Methods
IKKε expression in normal and OA human knee joints was analyzed immunohistochemically. Gain‐ or loss‐of‐function experiments were performed using human chondrocytes. Furthermore, OA was surgically induced in mice, followed by intraarticular injection of BAY‐985, an IKKε/TANK‐binding kinase 1 inhibitor, into the left knee joint every 5 days for 8 weeks. Mice were subsequently examined for histologic features of cartilage damage and inflammation.
Results
IKKε protein expression was increased in human OA cartilage. In vitro, expression levels of OA‐related factors were down‐regulated following knockdown of IKKε with the use of small interfering RNA in human OA chondrocytes or following treatment with BAY‐985. Conversely, IKKε overexpression significantly increased the expression of OA‐related catabolic mediators. In Western blot analysis of human chondrocytes, IKKε overexpression increased the phosphorylation of IκBα and p65. In vivo, intraarticular injection of BAY‐985 into the knee joints of mice attenuated OA‐related cartilage degradation and hyperalgesia via NF‐κB signaling.
Conclusion
These results suggest that IKKε regulates cartilage degradation through a catabolic response mediated by NF‐κB signaling, and this could represent a potential target for OA treatment. Furthermore, BAY‐985 may serve as a major disease‐modifying compound among the drugs developed for OA. image
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Kyushu University, Fukuoka, Japan.
- The Scripps Research Institute, La Jolla, California.
ORCID-Profile: Yukio Akasaki, Martin K Lotz
Förderung
- Japan Agency for Medical Research and Development
- Japan Society for the Promotion of Science
Zitieren
APA
Uchida, T., Akasaki, Y., Sueishi, T., Kurakazu, I., Toya, M., Kuwahara, M., Hirose, R., Hyodo, Y., Tsushima, H., Lotz, M. K., & Nakashima, Y. (2023). Promotion of Knee Cartilage Degradation by IκB Kinase ε in the Pathogenesis of Osteoarthritis in Human and Murine Models. Arthritis & Rheumatology. https://doi.org/10.1002/art.42421
Vancouver
Uchida T, Akasaki Y, Sueishi T, Kurakazu I, Toya M, Kuwahara M, et al. Promotion of Knee Cartilage Degradation by IκB Kinase ε in the Pathogenesis of Osteoarthritis in Human and Murine Models. Arthritis & Rheumatology. 2023. doi:10.1002/art.42421
BibTeX
@article{Uchida2023,
author = {Uchida, Taisuke and Akasaki, Yukio and Sueishi, Takuya and Kurakazu, Ichiro and Toya, Masakazu and Kuwahara, Masanari and Hirose, Ryota and Hyodo, Yuki and Tsushima, Hidetoshi and Lotz, Martin K and Nakashima, Yasuharu},
title = {Promotion of Knee Cartilage Degradation by IκB Kinase ε in the Pathogenesis of Osteoarthritis in Human and Murine Models},
journal = {Arthritis & Rheumatology},
year = {2023},
doi = {10.1002/art.42421}
}
EUVIMED